insights_auto
Zašto je 4559 pao 2,46%?
Istražite detaljnijechevron_right
4559:TYO
Zeria Pharmaceutical Co Ltd
1.903,00 JPY
arrow_downward
−2,46%(−48,00) 1D
2. lis, 13:30:23 GMT+9 · JPY
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 4559...
Otvori
1.938 JPY
Najviša
1.938 JPY
Najniža
1.895 JPY
Trž. kap.
95,38 mlr.
Prosj. kol.
162,22 tis.
Količina
161,70 tis.
Dividenda
2,57 %
Kvartalna dividenda
12 JPY
Datum nakon isplate dividende
29. ruj 2026.
P/E omjer
10,19
52-tjed. najviša
2.434 JPY
52-tjed. najniža
1.878 JPY
EPS
187 JPY
Dionice u optjecaju
50,11 mil.
Broj djelatnika
2 tis.
Otvori
1.938 JPY
Najviša
1.938 JPY
Najniža
1.895 JPY
Trž. kap.
95,38 mlr.
Prosj. kol.
162,22 tis.
Količina
161,70 tis.
Dividenda
2,57 %
Kvartalna dividenda
12 JPY
Datum nakon isplate dividende
29. ruj 2026.
P/E omjer
10,19
52-tjed. najviša
2.434 JPY
52-tjed. najniža
1.878 JPY
EPS
187 JPY
Dionice u optjecaju
50,11 mil.
Broj djelatnika
2 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Naslovi.net
·
prije 18 sati
Wall Street: Rast za S&P 500 na kraju rujna
Naslovi.net
·
prije 1 dan
Wall Street: Dow Jones pao drugi uzastopni dan
Action Forex
·
prije 14 minuta
Elliott Wave Outlook: DOW Futures (Ym) Bearish Sequence Targets 49570
marketscreener.com
·
prije 11 minuta
Can Treasuries rally for a second day?
Profil
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
Zeria Pharmaceutical Co Ltd – informacije
Glavni izvršni direktorSachiaki Ibe
Zaposlenici1,75 tis.
Osnovano22. pro 1955.
Sjedište-
Sektor-
Web-lokacijazeria.co.jp